Eton Pharmaceuticals Inc (ETON): Rasio rega marang dodolan

Logo korporat perusahaan Eton Pharma (ETON)

Eton Pharmaceuticals is developing a closed network of orphan drugs for endocrine pathologies, creating high switching costs. The company is implementing advanced molecule delivery methods, adapting drug formulations for pediatric needs. P/S volatility demonstrates revenue valuation dynamics, where 13.10 reflects the metric's baseline level. High margins and patent protection for niche drugs guarantee sustainable business growth.

ETON: Multiplikator P/S Eton Pharmaceuticals 04.07.2022 - 15.11.2026

Rincian metrik lan analitis perusahaan etonpharma.com (ETON)

Analisis umum perusahaan:ETON Eton Pharmaceuticals, Inc.
Produk dadi Eton Pharmaceuticals

The stability of the biomedical sector amid geopolitical neutrality provides Eton Pharmaceuticals (ETON) with a steady cash flow, making the analysis of revenue market value critically important. By examining the price-to-sales ratio on the GURU.Markets platform, an investor can see the relationship between market capitalization and actual turnover, allowing them to filter out speculative noise and determine the fair value of the business through the lens of verified financial facts.

Perusahaan pesaing

VRTX (Vertex Pharmaceuticals Incorporated) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Alnylam ALNY|INSM (Insmed Inc) - Rasio rega marang dodolan|United Therapeutics - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan BMRN (BioMarin Pharmaceutical)|BBIO: Multiplikator P/S|BGM Group Corp - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Cogent Bio|XERS: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan kerostx.com (KROS)|Kapitalisasi marang pendapatan Arcturus Therapeutics ARCT|Multiplikator P/S KMDA (kamada.com)|Multiplikator P/S Fulcrum Therapeutics, Inc. FULC|Abeona Therapeutics - Multiplikator P/S|mereobiopharma.com (MREO) - Kapitalisasi marang pendapatan|Protalix BioTherapeutics Inc. (PLX) - Rasio rega marang pendapatan|PLRX (Pliant Therapeutics Inc) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Applied Therapeutics, Inc.|Rein Therapeutics Inc. (RNTX) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan GELS (Gelteq Limited)|Multiplikator P/S Aytu Therapeutics (AYTU)|Rasio rega marang pendapatan Chemomab Therapeutics Ltd. CMMB|Rasio kapitalisasi pasar marang pendapatan SRXH|Polyrizon Limited - Multiplikator P/S|AEZS (zentaris.com) - Rasio kapitalisasi marang pendapatan|CYTH (Cyclo Therapeutics, Inc.) - Kapitalisasi marang pendapatan|Rega marang dodolan Inozyme Pharma, Inc. (INZY)|RPHM (Reneo Pharmaceuticals) - Multiplikator P/S|COSCIENS Biopharma (CSCI) - Koefisien rega marang pendapatan